Condition: Olfactory Neuroblastoma · Sponsor: Hongmeng Yu
The goal of this clinical trial is to learn about the induction chemotherapy efficacy in olfactory neuroblastoma. The main question it aims to answer is: wether olfactory neuroblastoma patients with different pathology subtypes apply to different induction chemotherapy schemes. Participants will be treated with different chemotherapy schemes, to evaluate the tumor remission rate and long term survival.
This description comes directly from the study's public registry record.
Xiaole Song, MD · 15821388769 · jxfxsxl@163.com
Jingyi Yang, MD · 19529941927 · yangjingyi_ent@163.com
Always discuss trial participation with your own doctor first.
| Eye & ENT Hospital of Fudan University | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06255210